Dyadic International Inc (DYAI)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Mark A. Emalfarb
Employees:
7
140 INTRACOASTAL POINTE DRIVE, SUITE 404, JUPITER, FL 33477
561-743-8333

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. It offers DYAI-100, SARS-CoV-2-S-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to serve as proof of concept for the development of next generation multivariant COVID-19 vaccine candidates.

Data derived from most recent annual or quarterly report
Market Cap 49.455 Million Shares Outstanding28.26 Million Avg 30-day Volume 27.408 Thousand
P/E Ratio0.069 Dividend Yield0.0 EPS-0.26
Price to Revenue0.2868 Debt to Equity0.0 EBITDA813.381 Million
Price to Book Value4.3257 Operating Margin296.1157 Enterprise Value40.07 Million
Current Ratio6.255 EPS Growth0 Quick Ratio6.067
1 Yr BETA 0.9536 52-week High/Low 4.28 / 1.12 Profit Margin415.6673
Operating Cash Flow Growth8.9818 Altman Z-Score195.8227 Free Cash Flow to Firm 564.294 Million
Earnings Report2023-03-28
View SEC Filings from DYAI instead.

View recent insider trading info

Dyadic International Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding DYAI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DYAI

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 5: filed on 2023-01-05 by KAYE JACK
  • 4: filed on 2023-01-05 by BOSE ARINDAM
  • 4: filed on 2023-01-05 by RAWSON PING WANG
  • 4: filed on 2023-01-05 by EMALFARB MARK A
  • 4: filed on 2023-01-05 by HAZELTON JOSEPH P
  • 4: filed on 2023-01-05 by TCHELET RONEN
  • 4: filed on 2023-01-05 by TARNOK MICHAEL P.
  • 4: filed on 2023-01-05 by KAYE JACK
  • 4: filed on 2023-01-05 by HERBST SETH
  • 4: filed on 2023-01-05 by BUCKLAND BARRY

    • Events (8k)

  • 8-K: filed on 2023-01-24:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-23:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-04:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-27:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-13:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-13:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-11:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    EMALFARB MARK A PRESIDENT AND CEO

    • Officer
    • Director
    • 10% Owner
    		 4,732,493 2023-01-03 1

    KAYE JACK

    • Director
    		 79,674 2023-01-03 3

    TARNOK MICHAEL P.

    • Director
    		 79,674 2023-01-03 2

    LUCY PATRICK K.

    • Director
    		 62,174 2023-01-03 2

    BUCKLAND BARRY

    • Director
    		 62,174 2023-01-03 2

    BOSE ARINDAM

    • Director
    		 79,674 2023-01-03 2

    TCHELET RONEN VP OF RESEARCH AND BUS. DVLPMT

    • Officer
    		 50,184 2023-01-03 2

    HERBST SETH

    • Director
    		 62,174 2023-01-03 2

    RAWSON PING WANG CHIEF FINANCIAL OFFICER

    • Officer
    		 159,851 2023-01-03 1

    HAZELTON JOSEPH P CHIEF BUSINESS OFFICER

    • Officer
    		 151,198 2023-01-03 1

    FRANCISCO TRUST UNDER AGREEMENT DATED FEBRUARY 28, 1996

    • 10% Owner
    		 3,548,528 2021-07-27 0

    JONES MATTHEW S. MANAGING DIR OF BD & LICENSING

    • Officer
    		 0 2021-01-04 0

    KITT BARRY M

    • 10% Owner
    		 4,363,589 2015-12-31 0

    KITT BARRY M

    PINNACLE FUND L P

    • 10% Owner
    		 1,959,172 2008-12-15 0

    KNOTT DAVID M

    • 10% Owner
    		 1,141,250 2007-10-31 0

    EMERSON STEVE

    • 10% Owner
    		 1,122,100 2007-10-31 0

    JUDA TOM

    JUDA NANCY

    • 10% Owner
    		 395,100 2007-10-31 0

    DELA POINTE LISA M INTERIM CHIEF FINANCIAL OFFICE

    • Officer
    		 1,000 2007-04-23 0

    MOOR WAYNE CHIEF FINANCIAL OFFICER

    • Officer
    		 332,889 2007-04-05 0

    SPROAT KENT MICHAEL EXEC VICE PRES - MANUFACTURING

    • Officer
    		 150,000 2007-04-05 0

    BONDAR ALEXANDER V VP - STRATEGY/CORP DEVELOPMENT

    • Officer
    		 110,000 2007-04-05 0

    NEDWIN GLENN E CHIEF SCIENCE OFFICER

    • Officer
    		 1,147,555 2007-04-05 0

    SHAPIRO ROBERT B

    • Director
    		 73,750 2007-01-02 0

    BERMAN RICHARD J

    • Director
    		 100,000 2007-01-02 0

    WARNER STEPHEN J

    • Director
    		 80,000 2007-01-02 0

    ROSENGART HARRY Z

    • Director
    		 71,667 2007-01-02 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    TCHELET RONEN - Officer VP OF RESEARCH AND BUS. DVLPMT

    		2023-01-05 19:29:22 -0500 2023-01-03 A 12,684 $1.38 a 12,684 direct -2.7778 13.1944 13.1944 6 -2.7778 2

    BOSE ARINDAM - Director

    		2023-01-05 19:30:45 -0500 2023-01-03 A 27,174 a 27,174 direct

    BOSE ARINDAM - Director

    		2023-01-05 19:30:45 -0500 2023-01-03 A 52,500 a 52,500 direct

    RAWSON PING WANG - Officer CHIEF FINANCIAL OFFICER

    		2023-01-05 19:30:29 -0500 2023-01-03 A 75,000 a 75,000 direct

    RAWSON PING WANG - Officer CHIEF FINANCIAL OFFICER

    		2023-01-05 19:30:29 -0500 2023-01-03 A 39,351 $1.38 a 84,851 direct -2.7778 13.1944 13.1944 6 -2.7778 2

    EMALFARB MARK A - Director - Officer - > 10% Owner PRESIDENT AND CEO

    		2023-01-05 19:30:03 -0500 2023-01-03 A 200,000 a 200,000 direct

    EMALFARB MARK A - Director - Officer - > 10% Owner PRESIDENT AND CEO

    		2023-01-05 19:30:03 -0500 2023-01-03 A 138,478 $1.38 a 4,532,493 direct -2.7778 13.1944 13.1944 6 -2.7778 2

    HAZELTON JOSEPH P - Officer CHIEF BUSINESS OFFICER

    		2023-01-05 19:29:44 -0500 2023-01-03 A 93,750 a 93,750 direct

    HAZELTON JOSEPH P - Officer CHIEF BUSINESS OFFICER

    		2023-01-05 19:29:44 -0500 2023-01-03 A 57,448 $1.38 a 57,448 direct -2.7778 13.1944 13.1944 6 -2.7778 2

    TCHELET RONEN - Officer VP OF RESEARCH AND BUS. DVLPMT

    		2023-01-05 19:29:22 -0500 2023-01-03 A 37,500 a 37,500 direct

    LUCY PATRICK K. - Director

    		2023-01-05 19:27:39 -0500 2023-01-03 A 35,000 a 35,000 direct

    TARNOK MICHAEL P. - Director

    		2023-01-05 19:29:11 -0500 2023-01-03 A 27,174 a 27,174 direct

    TARNOK MICHAEL P. - Director

    		2023-01-05 19:29:11 -0500 2023-01-03 A 52,500 a 52,500 direct

    KAYE JACK - Director

    		2023-01-05 19:28:43 -0500 2023-01-03 A 27,174 a 27,174 direct

    KAYE JACK - Director

    		2023-01-05 19:28:43 -0500 2023-01-03 A 52,500 a 52,500 direct

    HERBST SETH - Director

    		2023-01-05 19:28:26 -0500 2023-01-03 A 27,174 a 27,174 direct

    HERBST SETH - Director

    		2023-01-05 19:28:26 -0500 2023-01-03 A 35,000 a 35,000 direct

    BUCKLAND BARRY - Director

    		2023-01-05 19:28:02 -0500 2023-01-03 A 27,174 a 27,174 direct

    BUCKLAND BARRY - Director

    		2023-01-05 19:28:02 -0500 2023-01-03 A 35,000 a 35,000 direct

    LUCY PATRICK K. - Director

    		2023-01-05 19:27:39 -0500 2023-01-03 A 27,174 a 27,174 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    DYADIC INTERNATIONAL INC DYAI 2023-01-27 22:15:03 UTC 2.5514 1.7686 100000
    DYADIC INTERNATIONAL INC DYAI 2023-01-27 21:45:04 UTC 2.5514 1.7686 100000
    DYADIC INTERNATIONAL INC DYAI 2023-01-27 21:15:04 UTC 2.5514 1.7686 100000
    DYADIC INTERNATIONAL INC DYAI 2023-01-27 20:45:03 UTC 2.5514 1.7686 100000
    DYADIC INTERNATIONAL INC DYAI 2023-01-27 20:15:04 UTC 2.5514 1.7686 100000
    DYADIC INTERNATIONAL INC DYAI 2023-01-27 19:45:03 UTC 2.5514 1.7686 100000
    DYADIC INTERNATIONAL INC DYAI 2023-01-27 19:15:03 UTC 2.5514 1.7686 100000
    DYADIC INTERNATIONAL INC DYAI 2023-01-27 18:45:04 UTC 2.5514 1.7686 100000
    DYADIC INTERNATIONAL INC DYAI 2023-01-27 18:15:03 UTC 2.5514 1.7686 100000
    DYADIC INTERNATIONAL INC DYAI 2023-01-27 17:45:03 UTC 2.5514 1.7686 100000
    DYADIC INTERNATIONAL INC DYAI 2023-01-27 17:15:04 UTC 2.5514 1.7686 100000
    DYADIC INTERNATIONAL INC DYAI 2023-01-27 16:45:03 UTC 2.5443 1.7757 100000
    DYADIC INTERNATIONAL INC DYAI 2023-01-27 16:15:03 UTC 2.5443 1.7757 100000
    DYADIC INTERNATIONAL INC DYAI 2023-01-27 15:45:03 UTC 2.5443 1.7757 100000
    DYADIC INTERNATIONAL INC DYAI 2023-01-27 15:15:04 UTC 2.5443 1.7757 100000
    DYADIC INTERNATIONAL INC DYAI 2023-01-27 14:45:04 UTC 2.5443 1.7757 100000
    DYADIC INTERNATIONAL INC DYAI 2023-01-27 14:15:03 UTC 2.5443 1.7757 100000
    DYADIC INTERNATIONAL INC DYAI 2023-01-27 13:45:03 UTC 2.5443 1.7757 100000
    DYADIC INTERNATIONAL INC DYAI 2023-01-27 13:15:03 UTC 2.5443 1.7757 100000
    DYADIC INTERNATIONAL INC DYAI 2023-01-27 12:45:03 UTC 2.5443 1.7757 100000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund DYAI -900.0 shares, $-1719.0 2022-09-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments